Estrogen, HDL, and Coronary Heart Disease in Women

NCT00083824 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

309

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Disease
Heart Diseases
Coronary Arteriosclerosis

Interventions

DRUG: Estrogens, Conjugated (USP)
DRUG: Medroxyprogesterone 17-Acetate
DRUG: Placebo

Sponsor

Tufts University

Collaborators

[object Object]